Clinical Trial Detail

NCT ID NCT01746849
Title Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

acute myeloid leukemia

bone marrow cancer

acute lymphoblastic leukemia

non-Hodgkin lymphoma

myelodysplastic/myeloproliferative neoplasm

chronic myeloid leukemia

Therapies

Leuprolide

Cyclophosphamide

Thiotepa

Palifermin

Age Groups: adult

No variant requirements are available.